Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00225745
Status:
COMPLETED
Last Update Posted:
2015-10-14
First Post:
2005-09-22
Brief Title:
Ghrelin Levels in Pancreatic Cancer Patients
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Dartmouth-Hitchcock Medical Center
Study Overview
Official Title:
Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary outcome measure for this study is plasma ghrelin level
Detailed Description:
The primary outcome measure for this study is plasma ghrelin level and the two primary comparison are
Patients with cachexia versus patients without cachexia
Patients with cachexia versus healthy controls
Patients with cachexia versus patients without cachexia
Patients with cachexia versus healthy controls
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None